About

Activities

Please donate

Please support us
with your donation
Donate here

Member Area

Search

Member LogIn

Some areas of this website are accessible to registered members only.


If you have no account yet, please click on "Register". If you have forgotten your password, please click on "Forgot login?".

Members Online

None
You are here: Home Paediatric CML Scientific Publications

Scientific Publications

Paediatric CML Publications

This is a list of scientific publications on pediatric CML. If you are aware about additional publications, please This email address is being protected from spambots. You need JavaScript enabled to view it. - we would be delighted to make our list more complete! Thank you!

Display # 
Title Created Date
Bone metabolism, growth rate and pubertal development in children with chronic myeloid leukemia treated with imatinib during puberty (Giona et al) 25 September 2012
How I treat: childhood CML (Andolina et al, 2011) 30 December 2011
Imatinib Has Adverse Effect on Growth in Children With Chronic Myeloid Leukemia (Bansal 2011) 19 November 2011
Imatinib Is Effective in Children With Previously Untreated CML in Early Chronic Phase: Results of the French National Phase IV Trial (Millot 2011) 25 October 2011
CML in Children: Diagnostics and Management (Suttorp, Tauer, Millot 2011) 20 October 2011
Pediatric phase I trial and pharmacokinetic study of dasatinib (Aplenc, 2011) 20 October 2011
Distinct Impact of Imatinib on Growth at Prepubertal and Pubertal Ages of Children with CML (Shim et al, 2011) 18 May 2011
Stem cell transplantation for chronic myeloid leukemia in children (Cwynarski, 2003) 31 December 2002
Build it and they will come (or will they?) (Casper, 2003) 31 December 2002
Stem cell transplantation for chronic myeloid leukemia in children (Cwynarski 2003) 31 December 2002
Early blastic transformation following complete cytogenetic response in a pediatric chronic myeloid leukemia patient treated with imatinib mesylate (Morimoto) 31 December 2003
Treatment of CML in pediatric patients: should imatinib mesylate (STI-571, Gleevec) or allogeneic hematopoietic cell transplant be front-line therapy? (Pulsipher, 2004) 31 December 2003
Clinical and biological features at diagnosis in 40 children with chronic myeloid leukemia (Millot, 2005) 31 December 2004
Prognosis of pediatric patients transplanted for Ph+ chronic myeloid leukemia in the period from 1989 to 2006 in the Czech Republic (Krol, 2008) 31 December 2007
Molecular response of pediatric chronic myeloid leukemia (CML) with imatinib mesylate therapy (Basak, 2008) 31 December 2007
Allogeneic stem cell transplantation for pediatric and adolescent patients with CML: results from the prospective trial CML-paed I (Suttorp et al, 2009) 31 December 2008
Impact of imatinib on the in vitro osteoclastogenic differentiation of monocytes in children and adolescents with chronic myeloid leukemia (Jaeger, 2009) 31 December 2008
Outcome of 125 children with chronic myelogenous leukemia who received transplants from unrelated donors: the Japan Marrow Donor Program (Muramatsu et al, 2009) 31 December 2008
Clinical characteristics and treatment outcome of pediatric patients with chronic myeloid leukemia (Asim Belgaumi et al, 2009) 31 December 2008
Distinct Impact of Imatinib on Growth In Prepubertal and Pubertal Children with Chronic Myeloid Leukemia (Haruko Shima et al, 2010) 31 December 2009
Treatment of Pediatric CML in 2010: Use of Tyrosine Kinase Inhibitors and Stem Cell Transplantation (Suttorp et al, 2010) 31 December 2009
Differing Age Patterns in Chronic Myeloid Leukemia (CML) by Racial Ethnic Group (Levine at al, 2010) 31 December 2009
Clinical characteristics and treatment outcome of pediatric patients with chronic myeloid leukemia (Belgaumi et al, 2010) 31 December 2009
Controversies in treatment of CML in children and adolescents: TKI versus BMT? (Suttorp et al, 2011) 15 February 2011

© iCMLf International Chronic Myeloid Leukemia Foundation

digisesso